Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 10-2009 | 09-2009 | 07-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,180 | 2,659 | -9,392 | 1,931 | -6,957 |
| Depreciation Amortization | 740 | 386 | 502 | 329 | 363 |
| Income taxes - deferred | N/A | 1,140 | N/A | 1,140 | N/A |
| Accounts receivable | N/A | -1,855 | N/A | -1,496 | -9 |
| Accounts payable and accrued liabilities | 1,884 | -91 | 1,252 | -587 | 1,017 |
| Other Working Capital | 2,417 | -5,205 | 1,276 | -4,866 | 2,166 |
| Other Operating Activity | -7,158 | 2,299 | -303 | 2,205 | -709 |
| Operating Cash Flow | $-9,297 | $-667 | $-6,665 | $-1,344 | $-4,129 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -1,000 |
| PPE Investments | -332 | -1,319 | -51 | -761 | -5 |
| Purchase Sale Intangibles | -242 | N/A | -185 | N/A | -130 |
| Other Investing Activity | -242 | 0 | -185 | 0 | -130 |
| Investing Cash Flow | $-574 | $-1,319 | $-236 | $-761 | $-1,135 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,482 | N/A | 1,503 | N/A |
| Debt Issued | N/A | 800 | N/A | 800 | N/A |
| Debt Repayment | N/A | -296 | N/A | -198 | N/A |
| Common Stock Issued | 61,824 | N/A | 27,842 | N/A | 34,119 |
| Other Financing Activity | 0 | 0 | 33,982 | 0 | 5,683 |
| Financing Cash Flow | $61,824 | $1,986 | $61,824 | $2,105 | $39,802 |
| Beginning Cash Position | 6,119 | N/A | 6,119 | N/A | 6,119 |
| End Cash Position | 58,072 | N/A | 61,042 | N/A | 40,657 |
| Net Cash Flow | $51,953 | $0 | $54,923 | $N/A | $34,538 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,297 | -667 | -6,665 | -1,344 | -4,129 |
| Capital Expenditure | -332 | -1,319 | -51 | -761 | -5 |
| Free Cash Flow | -9,629 | -1,986 | -6,716 | -2,105 | -4,134 |